# PET/MR in Assessing Response to Neoadjuvant Radiation Therapy in the Tx of High Grade Sarcomas

> **NCT03076333** · NA · COMPLETED · sponsor: **UNC Lineberger Comprehensive Cancer Center** · enrollment: 3 (actual)

## Conditions studied

- Sarcoma

## Interventions

- **DIAGNOSTIC_TEST:** PET/MR

## Key facts

- **NCT ID:** NCT03076333
- **Lead sponsor:** UNC Lineberger Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-04-01
- **Primary completion:** 2019-12-30
- **Final completion:** 2020-01-31
- **Target enrollment:** 3 (ACTUAL)
- **Last updated:** 2021-03-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03076333

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03076333, "PET/MR in Assessing Response to Neoadjuvant Radiation Therapy in the Tx of High Grade Sarcomas". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03076333. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*